A group of internal emails by Johnson & Johnson officials-mostly from officials in the company’s Risperdal marketing division-provide a bird’s eye view of collusion between the drug giant and Harvard’s leading child psychiatrist, Dr. Joseph Biederman, and one of Harvard’s premier teaching hospitals, Massachusetts General Hospital.
"The committee’s concerns are part of a growing chorus of complaints about the increasing use of antipsychotic medicines in children and teenagers.
Sen. Grassley is peeling away psychiatry’s layers of deception about the efficacy and safety of its treatments: "I have come to understand that money from the pharmaceutical industry can shape the practices of nonprofit organizations that purport to be independent in their viewpoints and actions."
A follow-up letter to FDA Commissioner, Andrew vonEschenbach RE: Thomas Laughren, FDA’s ‘s Director of Psychiatry Products who has been actively promoting psychotropic drugs–even penning his name to ghostwritten industry-sponsored articles and consensus panels.
Complaint about a surge of FDA administrative approvals for expanded use of highly toxic antipsychotic drugs for children. Approvals were determined by Dr. Thomas Laughren after secret deliberations–without disclosure of scientific data, without an advisory panel or open public discussion.
A scientifically invalid study by financially compromised psychiatrists is but industy’s latest effort to rehabilitate SSRI antidepressants in the wake of public disclosure that these drugs DOUBLED the risk of suicidal acts.
Minnesota is the first of a handful of states to pass a law requiring drug manufacturers to disclose payments to doctors.
Are you aware that if you are in an accident in the U.S. your organs may be surgically removed without your consent?
"Daubert lets judges have much too much leeway to follow their personal inclinations," says Stanley Feldman, retired chief justice of the Arizona Supreme Court.
A new century has bred a group of young educated people openly supporting each other in a bid to consolidate their strengths:
The question is can these visits overcome industry's propaganda delivered under the guise of continuing medical education (CME) courses which physicians must take?
A commentary in the April 2007 issue of HARVAD magazine, AHRP board member, Stefan Kruszeuski, MD, urges his colleagues to abandon psychiatry’s diagnostic and therapeutic reductionism.
